Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01 and R21)
Application: Sep 8, 2020
Leveraging Population-based Cancer Registry Data to Study Health Disparities provides grants for research projects that use the existing cancer registry infrastructure by augmenting data already collected with additional information needed to understand health disparities among people diagnosed with cancer.
Research areas include:
- Understanding why some populations are less likely to receive recommended treatment
- Assessing the prognostic and predictive value of specific biomarkers in cancer incidence, progression, and treatment
- Understanding the role of behavior and lifestyle factors on recurrence and survival after diagnosis
- Impact of socio-economic status and location of residence on treatment received
- Urban/rural differences and differences in access to healthcare
- Role of cultural environment and social support on cancer outcomes
- Role of the mode of detection on differences in severity of disease at diagnosis and survival outcomes
R01 funding supports discrete, specified, circumscribed research projects.
R21 funding encourages new, exploratory, and developmental research projects by providing support for the early stages of project development.
Eligible applicants include
- State, county, city, township, or special district governments
- Independent school districts
- Public and private institutions of higher education
- Federally or state recognized tribal governments
- Public and Indian housing authorities
- Native American tribal organizations
- Nonprofits with or without 501(c)(3) status
- For-profit organizations and small businesses
R01 application budgets are not limited, but need to reflect the actual needs of the proposed project.
For R21 projects, the combined budget for direct costs for the 2 year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
Standard deadlines apply for R01 new, resubmission, and revision applications and R21 new applications. While not required, it is suggested that a letter of intent be submitted by email to Nadia Howlader at least 30 days before the application deadline.
Note that there are two CFDA numbers assigned to this program.
- 93.393 - Cancer cause and prevention research
- 93.399 - Cancer control research
For complete information about funding programs, including your application status, please contact funders directly. Summaries are provided for your convenience only. RHIhub does not take part in application processes or monitor application status.